Effect of Darbepoetin in Contrast-induced Nephropathy
Prevention of Contrast-Induced Nephropathy by Darbepoetin in Patients With Chronic Kidney Disease
Sponsor: SMG-SNU Boramae Medical Center
Terminated
difficult to enroll targeted participants
Other terminated trials from SMG-SNU Boramae Medical Center
Other Acute Kidney Injury trials with similar outcome
A PHASE2/PHASE3 clinical study on Acute Kidney Injury, this trial is terminated or withdrawn. The trial is conducted by SMG-SNU Boramae Medical Center and has accumulated 6 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE2/PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE2_PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE2_PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE2_PHASE3
First recorded
May 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- SMG-SNU Boramae Medical Center
- Seoul National University Bundang Hospital
For direct contact, visit the study record on ClinicalTrials.gov .